Energy Specific Far Infrared Radiation Treatment for Erectile Dysfunction

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2009 by GAAD Medical Research Institute Inc..
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
GAAD Medical Research Institute Inc.
ClinicalTrials.gov Identifier:
NCT00573209
First received: December 12, 2007
Last updated: August 14, 2009
Last verified: August 2009

December 12, 2007
August 14, 2009
August 2007
February 2009   (final data collection date for primary outcome measure)
The primary end point is to determine the therapeutic effects of far infrared radiation on erectile dysfunction. [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00573209 on ClinicalTrials.gov Archive Site
The effect of far infrared radiation on other male conditions like prostate cancer [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Energy Specific Far Infrared Radiation Treatment for Erectile Dysfunction
Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Erectile Dysfunction.

A preliminary study to determine the possibility of using far infrared (FIR) radiation to treat impotency.

Erectile dysfunction is characterized by the regular or repeated inability to obtain or maintain an erection. Erection depends on a complex interaction of psychological, neural, vascular and endocrine factors.

We are proposing a non-drug and a non-invasive radiation treatment for the enhancement of erection.

Interventional
Phase 1
Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Erectile Dysfunction
Radiation: Far Infrared Radiation
Far Infrared Radiation (5μm to 20μm wavelength) for 30 to 40 minutes each session.
1
Intervention: Radiation: Far Infrared Radiation
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
3
May 2009
February 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Persons with erection challenges

Exclusion Criteria:

  • None
Male
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
Canada
 
NCT00573209
GAAD-EDS-CTP1
Yes
Dr. Kwasi Donyina/Founder & President, GAAD Medical Research Institute inc.
GAAD Medical Research Institute Inc.
Not Provided
Study Director: Ken Nedd, M.D. GAAD Medical Research Institute Inc.
Study Chair: Kwasi Donyina, Ph.D. GAAD Medical Research Institute Inc.
GAAD Medical Research Institute Inc.
August 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP